IL18 and atherosclerosis: According to this hypothesis, circulating inflammatory mediators such as TNF-α and IL-18, which are closely associated with endothelial dysfunction and cardiovascular disease [33–35], may induce vascular injury, aggravate the burden of atherosclerosis, and lead to higher cardiovascular morbidity and mortality, as seen in AF subjects [36].